Guo, Zhuyan
Merck & Co., Inc., Rahway, NJ, USA (United States)
2 papers on CoChat
Most cited papers
- Verified
SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models
Shomali, M., Cheng, J., Sun, F., Koundinya, M., Guo, Z., Hebert, A. T., McManus, J., Levit, M. N., Hoffmann, D., Courjaud, A., et al. (2021) · Molecular Cancer Therapeutics
Estrogen and related hormone effectsAdvanced Breast Cancer Therapies
Cited by 69
- Verified
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
Hodder, A. N., Christensen, J., Scally, S., Triglia, T., Ngo, A., Birkinshaw, R. W., Bailey, B., Favuzza, P., Dietrich, M. H., Tham, W.-H., et al. (2022) · Structure
Malaria Research and ControlProtease and Inhibitor Mechanisms
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free